ADIPOQ rs2241766: What Your Genotype Means
The rs2241766 variant is a common genetic change located within the ADIPOQ gene, which provides instructions for making the hormone adiponectin. Research has explored its potential associations with insulin sensitivity, obesity, and cardiovascular health, though findings often vary by population.
What each genotype means
Common baseline genotype
This is the most common genotype for this variant. Research indicates that individuals with this genotype may have different obesity risk profiles compared to those carrying the G allele, particularly in East Asian populations where the G allele has been linked to increased susceptibility.
This is the most frequently observed genotype across most global populations.
Intermediate risk profile
Carrying one copy of the G allele may influence adiponectin-related metabolic traits. Some studies suggest a potential association with slightly altered obesity risk or breast cancer risk, though findings remain inconsistent across different ancestral groups.
This heterozygous genotype is found at moderate frequencies, particularly in East Asian populations.
Increased obesity risk association
This genotype has been associated with an increased risk for obesity in some studies, specifically within Chinese populations. The association is not consistently observed in non-Chinese cohorts, suggesting that the impact of this variant is highly dependent on genetic background.
This is the least common genotype, occurring at lower frequencies in most populations.
Understanding the rs2241766 Variant
The rs2241766 variant is a single nucleotide polymorphism (SNP) located on chromosome 3 at position 3q27.3. In genetic terms, this variant is classified as a synonymous change, meaning that while it alters the DNA sequence, it does not change the amino acid sequence of the resulting protein. Despite being synonymous, researchers study this SNP because it may be in linkage disequilibrium with other functional variants or influence the regulation of gene expression. It sits within the ADIPOQ gene, which is highly expressed in adipose tissue. Because this gene is central to metabolic regulation, scientists frequently investigate how variations here might correlate with physiological differences in how the body processes glucose and fats. It is important to note that genetic associations are statistical observations across large groups and do not predict individual health outcomes.
The Role of the ADIPOQ Gene
The ADIPOQ gene encodes adiponectin, a hormone secreted primarily by fat cells that circulates in the bloodstream. Adiponectin acts as a master regulator of metabolism, playing a critical role in enhancing insulin sensitivity and promoting the oxidation of fatty acids in tissues like the liver and muscles. By activating the AMPK pathway, adiponectin helps the body maintain healthy glucose levels and exerts anti-inflammatory and anti-atherogenic effects. Because of these functions, the gene is a primary focus for researchers studying metabolic syndrome, type 2 diabetes, and obesity. When the production or function of adiponectin is altered, it can impact how the body manages energy storage and insulin response. Understanding the genetic variations within this gene helps scientists map the complex pathways that link adipose tissue function to systemic metabolic health.
Research and Evidence Strength
Evidence linking rs2241766 to specific health traits is considered moderate and often context-dependent. Numerous studies have examined its association with obesity and metabolic conditions, but results have been inconsistent across different ethnic groups. For instance, some meta-analyses have suggested an association with obesity in Chinese populations that was not replicated in other cohorts. Additionally, recent research has looked at the role of this variant in cardiovascular risk, with some studies finding that specific genotypes may correlate with an increased risk of acute myocardial infarction in patients with type 2 diabetes. Because these findings are highly dependent on the population studied and the presence of other environmental or genetic factors, the evidence is not considered definitive. It is essential to view these statistical associations as part of a broader, complex picture of human health rather than as direct causes of disease.
Interpreting Your Genetic Information
If you have received information about your rs2241766 genotype, it is important to understand that this is only one small piece of a very large biological puzzle. Genetic variants like this do not function in isolation; they interact with your diet, physical activity, lifestyle, and thousands of other genes. You cannot use this information to diagnose yourself with a condition or to predict your future health with certainty. If you are concerned about your metabolic health, insulin sensitivity, or weight management, the most effective approach is to consult with a healthcare professional or a registered dietitian. They can provide personalized guidance based on your clinical history, blood work, and overall wellness goals. Never make changes to your medical care or medication regimen based on genetic test results without first discussing them with your doctor or pharmacist.
How common is this variant?
The rs2241766 variant is common, with a global minor allele frequency of approximately 14%. It is particularly well-studied in East Asian populations, where its frequency and association with metabolic traits have been a focus of significant research.
Frequently asked questions
Is rs2241766 a cause of obesity?
No, rs2241766 is not a direct cause of obesity. It is a genetic variant that has shown statistical associations with obesity in some studies, but these findings are inconsistent and likely influenced by other genetic and environmental factors.
Can I use this SNP to predict my diabetes risk?
Genetic variants like rs2241766 provide only a tiny fraction of information regarding diabetes risk. Clinical factors such as blood glucose levels, family history, and lifestyle are much more significant predictors of your health.
What should I do if I have the G/G genotype?
The G/G genotype is a common variation and does not require specific medical action. You should focus on established healthy habits like a balanced diet and regular exercise, and discuss any health concerns with your primary care provider.
Why do study results for this variant differ?
Research results often vary due to differences in study design, the ethnic background of the participants, and the influence of environmental factors. This is common in genetic research, where a variant may show an effect in one population but not another.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2241766?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADIPOQ
Common regulatory promoter polymorphism in the adiponectin gene associated with circulating adiponectin levels and insulin sensitivity.
A variant in the ADIPOQ gene linked to inflammatory regulation and insulin sensitivity in the context of dietary intake.
Common promoter variation (-11391G>A) in the adiponectin gene associated with circulating adiponectin levels and risk of insulin resistance.
This SNP in the adiponectin gene is associated with insulin sensitivity and metabolic syndrome risk.
This SNP is studied for its role in adiponectin levels and metabolic response to diet.
This SNP is associated with circulating adiponectin levels and metabolic syndrome risk.